TheEdgeResearch
Home / Stocks / HULCF

Hulic Co., Ltd. (HULCF)

OTC Real Estate Real Estate - Services
$9.17 ▲ +0.00%
Market Cap
$6.96B
Sector
Real Estate
Industry
Real Estate - Services
Beta
0.37
52-Wk Range
9.136-10.8
CEO
Takaya Maeda
Country
JP
Currency
USD

Hulic Co., Ltd. operates in the Real Estate - Services industry of the Real Estate sector, headquartered in Tokyo, TY, JP. The stock last traded at $9.17, up 0.00% on the session, giving a market capitalisation of $6.96B. On trailing twelve-month figures it carries a trailing P/E of 11.11, a net margin of 14.1%. Its beta of 0.37 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
11.11
Price / Sales
1.57
Price / Book
1.40
EV / EBITDA
15.41
Gross margin
35.3%
Operating margin
22.8%
Net margin
14.1%
Return on equity
Debt / equity
2.40
Current ratio
1.81
Dividend yield
3.8%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3,495
IPO date
2016-11-14
Headquarters
Tokyo, TY, JP
About Hulic Co., Ltd.

Hulic Co., Ltd. is a prominent Japanese firm specializing in the development, leasing, sale, and brokerage of real estate assets across Japan. The company's operations are structured into three primary segments: Real Estate, Insurance, and Hotels & Inns. Its extensive property portfolio encompasses a diverse array of assets, including office buildings, commercial spaces, residential rental units, and various hospitality properties. As of December 31, 2021, Hulic managed a portfolio of roughly 265 leased properties. Beyond its core real estate activities, the company also engages in asset management and functions as an insurance agency, complementing its broader business scope. Established in 1931, Hulic Co., Ltd. maintains its headquarters in Tokyo, Japan.

Comparable companies

Hulic Co., Ltd. is most often compared with the following Real Estate names:

CLILFCPNNFIFSUFLEGIFLGFRYLNGPFPSPSFSCOTFSWPRFWARFF
More research on HULCF
HULCF technical analysis HULCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →